5th Cytokine-Based Drug Development Summit 2024
Evvnt Promotion / evvnt
21.05.2024 - 23.05.2024 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 9:00 AM - 4:25 PM
Kongressthemen
While leading cytokine therapeutic developers are using next-generation cytokine engineering technologies to tackle enduring efficacy and toxicity challenges to take their molecules through the clinic, the field is also looking to novel targets, novel cytokines and an expanded disease focus.
While leading cytokine therapeutic developers are using next-generation cytokine engineering technologies to tackle enduring efficacy and toxicity challenges to take their molecules through the clinic, the field is also looking to novel targets, novel cytokines and an expanded disease focus.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2140304-3?pid=4832
Speakers: Aaron Meyer, Assistant Professor, UCLA, Audrey Le Floc’h, Associate Director, Regeneron, Bertolt Kreft, Chief Scientific Officer, Bright Peak Therapeutics, and more
URL:
Brochure: https://go.evvnt.com/2140304-3?pid=4832
Speakers: Aaron Meyer, Assistant Professor, UCLA, Audrey Le Floc’h, Associate Director, Regeneron, Bertolt Kreft, Chief Scientific Officer, Bright Peak Therapeutics, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2140304-2?pid=4832
Herr Hanson Wade
Onkologie
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
